English

Global Importance

The Biopharmaceutical industry has made a capital investment of approximately $10 billion in new facilities in Ireland, most of which has come in the last 10 years. This represents close to the biggest wave of investment in new BioTech facilities anywhere in the world.

Deep Pool of Talent

Ireland has one of the youngest and most highly educated populations in Europe. This provides a rich and strong pool of talent for the sector, which continues to benefit from high levels of investment in third-level education and the growth of collaborative clusters.

Education

Ireland’s universities in the fields of Engineering, Chemistry, Bio Chemistry and Bio Technology have strong cooperative links with the sector. Feedback from the industry in terms of its skills needs feeds directly into the universities and drives Ireland’s pursuit of Biopharmaceutical academic excellence.

Track Record

Manufacturing excellence in Biopharmaceuticals is a hallmark of Ireland's success in the sector. This is constantly driving growth in the likes of Bio Tech, which has developed from two manufacturing sites in 2003 to 18 in 2017.

Regulation & standards

Ireland has an exemplary compliance record with regulatory agencies, including HPRA, FDA and EMA. They work closely with companies to achieve trouble-free compliance. Certification agencies in Ireland operate in accordance with European and global standard procedures.

International Reputation

Ireland’s regulatory track record is excellent and the Health Product Regulatory Authority (HPRA), boasts an international reputation in regulatory compliance.

Drive for Excellence

The HPRA has recently initiated Regulatory Science Ireland to explore opportunities for investment in research to increase understanding around processes and products, and thereby support Ireland’s reputation for regulatory excellence in manufacturing.

RESEARCH & DEVELOPMENT

Ireland has a significant track record of clinical and academic research excellence. The government has also committed €8 billion to research funding to further bolster Ireland’s reputation as a growing hub for research and development.

Training Centre

The National Institute for Bioprocess Research and Training (NIBRT), created from a €60million investment by the IDA, gave practical training to 2,000 people in 2013. Senior executives from the sector sit on the NIBRT board in the knowledge that the availability of suitably trained staff is a key determinant of success in Biopharmaceutical manufacturing.

Funding

Science Foundation Ireland (SFI) funds a lot of basic research in the Biopharmaceutical sector, especially with regards to understanding cancer, autoimmune disease and Alzheimer’s. Recently SFI announced a deal with Pfizer, whereby both parties are jointly funding basic Bio Medical research, which will help support Pfizer’s drug discovery efforts here in Ireland and globally.

BIOPHARMACEUTICALS IN IRELAND

Explore the current business landscape in Ireland and see what's happening on the ground now.

Previous
Bausch and Lomb Waterford
Next
SEE ALL VIDEOS

Contact the BIOPHARMACEUTICALS TEAM

Contact us

Contact IDA Ireland

You'll find us responsive to your needs, proactive, professional and willing to go the extra mile.

Contact IDA Ireland

International Offices

We have 28 Offices worldwide helping support companies expand their operations in Ireland.

Find your nearest office
IDA Ireland uses small cookies to improve your website experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.